Moreover, in vivo studies have shown that GBMs, without constitutively active EGFR signaling, were resistant to the inhibition of FA synthesis, whereas the insertion of vIII mutation sensitized tumor cells in GBM xenograft models [50]. Here, EGFR is linked to glioblastoma.